Every S-1 that Mobix Labs, Inc. (MOBX) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A S-1 covers the registration statement a company files to sell shares publicly, so if you follow MOBX and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full MOBX filings page.
Mobix Labs, Inc. (MOBX) has filed an S-1 to register the resale of up to 5,000,000 shares of Class A Common Stock by a selling stockholder. These shares are issuable upon conversion of Series A 10% Convertible Preferred Stock, including shares issuable from exercising an August 2026 preferred stock purchase warrant. Mobix is not selling any shares in this offering and will receive no proceeds from the resale, though it may receive up to $6,000,000 if the warrant is exercised, which it plans to use for working capital and general corporate purposes.
The 5,000,000 shares represent approximately 22.9% of the 16,847,921 Class A shares outstanding as of August 24, 2026, creating a sizable potential overhang that the company warns could pressure its share price. Mobix reports substantial operating losses, an accumulated deficit of $183.4 million as of June 30, 2026, and explicitly notes substantial doubt about its ability to continue as a going concern, highlighting a need for additional capital. The company details restrictive and potentially dilutive preferred stock and convertible note financings with Kips Bay Select, LP and Leviston Resources, LLC, planned acquisitions of Vision Aerial, Inc. and Special Project Delivery, Inc., and a strategic shift toward its National Security Matters Initiative, while also flagging risks including Nasdaq listing compliance, customer concentration, material weaknesses in internal controls, and significant future dilution from convertible instruments.
Mobix Labs, Inc. is registering up to 3,744,161 shares of Class A Common Stock for resale by existing stockholders. The shares include stock issued on debt settlements, litigation settlement and RaGE Systems earnout, plus shares issuable from new Series A 10% Convertible Preferred Stock and a related warrant. Mobix will not receive proceeds from these resales but may receive up to $6,000,000 if the Preferred Warrant is exercised, for working capital and general corporate purposes.
As of June 8, 2026, 14,998,187 Class A and 200,491 Class B shares were outstanding, and the offered shares would equal about 25% of Class A. The company reports large operating losses, substantial doubt about its ability to continue as a going concern, plans for further dilutive financings and multiple acquisition initiatives, all detailed in extensive risk factors.
Mobix Labs, Inc. is registering up to 3,744,161 shares of Class A Common Stock for resale by existing holders. The company will not receive proceeds from these resales but may receive up to $6,000,000 if a related preferred stock warrant is exercised, which it plans to use for working capital and general corporate purposes.
As of June 8, 2026, Mobix had 14,998,187 Class A and 200,491 Class B shares outstanding, and the registered shares represent about 25% of the Class A float, creating potential stock overhang. Mobix is an early-stage, unprofitable semiconductor and connectivity company with substantial accumulated losses, material weaknesses in internal controls, and explicit going-concern risks, and it expects to seek additional dilutive financing for operations and planned acquisitions.
Mobix Labs, Inc. has filed a resale registration statement covering up to 2,500,000 shares of Class A Common Stock issuable upon conversion of a $3,000,000 senior secured convertible promissory note held by Leviston Resources. All registered shares may be sold from time to time by the selling stockholder, and Mobix will not receive proceeds from these resales.
The company states that, assuming full issuance, the registered shares would equal about 23.94% of Class A Common Stock outstanding as of April 16, 2026, creating a potential overhang that could pressure the stock price. Mobix’s Class A stock is listed on Nasdaq under “MOBX,” and there is an existing 1‑for‑10 Reverse Stock Split already reflected in share figures.
Mobix highlights significant risks: it is an early-stage business with recurring operating losses, substantial doubt about its ability to continue as a going concern, heavy customer concentration, the need to raise additional capital, Nasdaq listing compliance concerns, and identified material weaknesses in internal control over financial reporting.
Mobix Labs, Inc. is registering the resale of up to 24,127,116 shares of its Class A Common Stock for existing selling stockholders. The company itself is not selling shares and will receive no proceeds from these resales.
The registered shares include stock issued in financings and acquisitions, such as 16,161,787 warrant shares and 3,856,854 shares issued for the RaGE Systems acquisition. As of January 31, 2026, Mobix had 101,072,226 Class A and 2,004,901 Class B shares outstanding.
Mobix may receive up to approximately $15.6 million in gross cash proceeds only if certain outstanding warrants covered by this registration are exercised for cash. The filing emphasizes that the registered block is large, representing about 23.9% of Class A shares, and that resales, or expectations of resales, could significantly pressure the stock price.
Mobix Labs, Inc. (MOBX) filed an amended Form S-1 registering the resale of up to 12,890,274 shares of Class A common stock by selling stockholders. The company is not selling any shares in this offering and will not receive proceeds from stockholder sales.
If outstanding warrants covered by this prospectus are exercised for cash, Mobix Labs states it would receive approximately $9.8 million in gross proceeds. The filing notes the registered shares would equal about 18% of outstanding Class A shares as of September 4, 2025, and that resales—or the perception of them—could pressure the trading price.
The prospectus also highlights recent financing activities. On September 3, 2025, a holder exercised 5,486,467 warrants for cash at $0.8202 per share, generating ~$4.5 million in gross proceeds, and received new inducement warrants for 8,229,701 shares at $1.08. On August 13, 2025, the company issued a $550,000 senior secured note convertible at $0.70 (up to 2,500,000 shares), with 150,000 commitment shares and caps including a 4.99% beneficial ownership limit and an exchange cap of 5,747,105 shares.